PMID: 18193579Jan 16, 2008Paper

Comparative analysis of efficacy of certain neuroprotectors in ischemic stroke

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
A P SkorokhodovA A Sedova

Abstract

Cortexin, nootropil and cerebrolysin have been used as neuroprotective medications in the acute period of ischemic stroke (IS). Clinical efficacy of cortexin and nootropil has been compared in 2 therapeutic series in 35 patients and that of cortexin and cerebrolysin--in 45 patients. The efficacy was assessed using several clinical and psychometric scales with statistical processing of the results. The data obtained suggest that in patients with moderate IS the drugs exert a similar and rather marked effect which was stronger comparing to the treatment without these drugs. At the same time, a domestic neuroprotector cortexin has some advantages, especially with regard to the absence of side-effects and "price-dose-therapeutic effect" criterion.

Related Concepts

Related Feeds

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Related Papers

Stroke; a Journal of Cerebral Circulation
Wolf-Dieter HeissCerebrolysin Acute Stroke Treatment in Asia (CASTA) Investigators
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
I M ShetovaA Iu Botsina
Revista de neurologia
F Abad-SantosM A Gálvez-Múgica
© 2021 Meta ULC. All rights reserved